Related Experiment Video
Updated: Jun 4, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
The CYLD-PARP1 feedback loop regulates DNA damage repair and chemosensitivity in breast cancer cells
Miaomiao Zheng1, Shuo Wang1, Kexin Tang1
1Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, Department of Biochemistry and Molecular Biology, College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, China.
Abstract:
Poly(ADP-ribose) polymerase 1 (PARP1) plays a crucial role in DNA repair and genomic stability maintenance. However, the regulatory mechanisms governing PARP1 activity, particularly through deubiquitination, remain poorly elucidated. Using a deubiquitinase (DUB) library binding screen, we identified cylindromatosis (CYLD) as a bona fide DUB for PARP1 in breast cancer cells. Mechanistically, CYLD is recruited by PARP1 to DNA lesions upon genotoxic stress, where it cleaves K63-linked polyubiquitin chains on PARP1 at residues K748, K940, and K949, resulting in compromised PARP1 activation. In a reciprocal manner, PARP1 PARylates CYLD at sites E191, E231, E259, and E509, thereby enhancing its DUB activity. Consequently, depletion of CYLD leads to increased efficiency in base excision repair and confers breast cancer cells with resistance to alkylating agents. Conversely, overexpression of CYLD enhances sensitivity to PARP inhibitors (PARPi) even in homologous recombination-proficient breast cancer cells. These findings offer unique insights into the intricate interplay between CYLD and PARP1 in DNA repair, underscoring the pivotal role of targeting this regulatory axis for breast cancer chemotherapy.
Insights
Cylindromatosis (CYLD) deubiquitinates Poly(ADP-ribose) polymerase 1 (PARP1), impacting DNA repair in breast cancer. Targeting this CYLD-PARP1 interaction may enhance chemotherapy efficacy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Poly(ADP-ribose) polymerase 1 (PARP1) is vital for DNA repair and genomic stability.
- Regulatory mechanisms of PARP1, especially deubiquitination, are not fully understood.
Purpose of the Study:
- To identify deubiquitinases (DUBs) regulating PARP1 activity.
- To elucidate the role of CYLD in PARP1 regulation and its implications in breast cancer.
Main Methods:
- Utilized a DUB library binding screen to identify PARP1-interacting DUBs.
- Investigated the mechanistic interplay between CYLD and PARP1 at DNA lesions.
- Assessed the impact of CYLD modulation on DNA repair pathways and drug sensitivity in breast cancer cells.
Main Results:
- Identified cylindromatosis (CYLD) as a deubiquitinase for PARP1 in breast cancer cells.
- CYLD cleaves K63-linked polyubiquitin chains on PARP1, reducing its activation.
- PARP1 PARylates CYLD, enhancing its deubiquitinase activity.
- CYLD depletion increases base excision repair efficiency and confers resistance to alkylating agents.
- CYLD overexpression sensitizes breast cancer cells to PARP inhibitors (PARPi).
Conclusions:
- Established a reciprocal regulatory relationship between CYLD and PARP1 in DNA repair.
- CYLD deubiquitination of PARP1 is a critical mechanism controlling DNA repair efficiency.
- The CYLD-PARP1 axis represents a potential therapeutic target for breast cancer chemotherapy.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Long-patch Base Excision Repair
Inhibition of Cdk Activity

